CHEM2052 Tutorial Example4
From Proteopedia
(Difference between revisions)
| Line 1: | Line 1: | ||
==CHEM2052_Tutorial_Example4== | ==CHEM2052_Tutorial_Example4== | ||
<StructureSection load='2i4q' size='450' side='right' caption='Renin (PDB code [[2i4q]])'> | <StructureSection load='2i4q' size='450' side='right' caption='Renin (PDB code [[2i4q]])'> | ||
| - | == '''Chem2052: Example | + | == '''Chem2052: Example 4 - Renin''' == |
| + | |||
| + | == Background == | ||
| + | |||
| + | In later lecture we will look at an enzyme called '''Renin''' (also known as '''angiotensinase). This enzyme is involved in a biological pathway leading to elevation of blood pressure, which can be beneficial in many ways. However if this process has become overactive, hypertension (high blood pressure) can result. Hypertension leads to cardiovascular disease which is the leading cause of death globally. The World Health Organisation states "An estimated 17.3 million people died from cardiovascular disease in 2008, representing 30% of all global deaths" see the following web page if you want to know more: [http://www.who.int/mediacentre/factsheets/fs317/en/]. | ||
| + | |||
| + | Since the 1970s scientists have been trying to modulate the action of renin by blocking the active site of the enzyme and preventing its function, hence lowering blood pressure. Aliskerin is the only renin inhibitor in clinical use today [http://en.wikipedia.org/wiki/Renin_inhibitor Renin information Site]. However there is still interest in developing new, improved inhibitors. This question looks at a renin inhibitor identified through research at Pfizer. | ||
| + | |||
| + | == '''Active Sites''' == | ||
| + | |||
| + | This representation illustrates the active site catalytic residues of Renin. | ||
| + | <scene name='55/559112/Renin_catalytic_residues/1'>Renin Catalytic Residues</scene> | ||
| + | <scene name='55/559112/Renin_catalytic_residues/1'>Renin Catalytic Residues</scene> | ||
'''Serine proteases''' account for over one-third of all known proteolytic enzymes <ref>PMID:17991683</ref>,<ref name="DiCera">PMID:19180666</ref>. Within the diverse collection of serine proteases, the most famous members are trypsin, chymotrypsin and elastase. Aside from their key roles in digestion (and other physiological processes) <ref name ="DiCera"/>, the unique specificities of these enzymes make them useful tools in biochemistry and molecular biology to ascertain protein sequences. | '''Serine proteases''' account for over one-third of all known proteolytic enzymes <ref>PMID:17991683</ref>,<ref name="DiCera">PMID:19180666</ref>. Within the diverse collection of serine proteases, the most famous members are trypsin, chymotrypsin and elastase. Aside from their key roles in digestion (and other physiological processes) <ref name ="DiCera"/>, the unique specificities of these enzymes make them useful tools in biochemistry and molecular biology to ascertain protein sequences. | ||
| Line 11: | Line 23: | ||
*<scene name='User:Amy_Kerzmann/Sandbox_5/New_elastase-triad/3'>Elastase</scene> | *<scene name='User:Amy_Kerzmann/Sandbox_5/New_elastase-triad/3'>Elastase</scene> | ||
| - | == '''Active Sites''' == | ||
| - | <scene name='55/559112/Renin_catalytic_residues/1'>Renin Catalytic Residues</scene> | ||
| - | == Background == | ||
| - | |||
| - | In later lecture we will look at an enzyme called Renin (also known as angiotensinase). This enzyme is involved in a biological pathway leading to elevation of blood pressure, which can be beneficial in many ways. However if this process has become overactive, hypertension (high blood pressure) can result. Hypertension leads to cardiovascular disease which is the leading cause of death globally. The World Health Organisation states "An estimated 17.3 million people died from cardiovascular disease in 2008, representing 30% of all global deaths" see the following web page if you want to know more: [http://www.who.int/mediacentre/factsheets/fs317/en/]. | ||
| - | Since the 1970s [http://en.wikipedia.org/wiki/Renin_inhibitor Renin Wikipedia Site] scientists have been trying to modulate the action of renin by blocking the active site of the enzyme and preventing its function, hence lowering blood pressure. Aliskerin is the only renin inhibitor in clinical use today. However there is still interest in developing new, improved inhibitors. This question looks at a renin inhibitor identified through research at Pfizer. | ||
Revision as of 04:25, 13 August 2014
CHEM2052_Tutorial_Example4
| |||||||||||
References
- ↑ Rawlings ND, Morton FR, Kok CY, Kong J, Barrett AJ. MEROPS: the peptidase database. Nucleic Acids Res. 2008 Jan;36(Database issue):D320-5. Epub 2007 Nov 8. PMID:17991683 doi:10.1093/nar/gkm954
- ↑ 2.0 2.1 Di Cera E. Serine proteases. IUBMB Life. 2009 May;61(5):510-5. PMID:19180666 doi:10.1002/iub.186

